TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of re-hospitalisations for positive or close margins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Probing Depth (PD) reduction in deep pockets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Attachment Level (CAL) reduction in deep pockets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician’s Global Assessment of Disease Activity (PhGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global cognition performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: HPV clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cure rate of strabismus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular–monocular function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of diaphragmatic paralysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rate of partial paralysis of the diaphragm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ISI score reduction
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Reduction in use of hypnotic drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: RPEs apoptotic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean red fluorescence intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RTRA (Respiratory Tract Recovery Assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Post-treatment EEG scores at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prolongation of block duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery 15 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Constant-severe pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body mass index-for-age z-score (BAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PMP number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage inhibition of ADP-induced platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: tDCS treatment adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: tDCS-related adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: rate of hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Time to eyes opening on command
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to ability to answer simple questions (age and name)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AEP scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: QOLIE‐31 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: NRS score at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS score while coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total postoperative sufentanil consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescriptive size standards for fetal brain structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to achieve 90% of train‐of‐four (TOF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular outcomes
Primary endpoint: Target attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of pemetrexed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life associated with the procedure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Duration of uterine artery embolization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants achieving ?10% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diaphragm descending movement and TrA and IO thickness differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NHTAS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability worsening at 36 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in retinal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of progressively motile sperm (PMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: percentage of morphologically normal sperm (MNS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: maximal expiratory pressure (MEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dietary Well‐Being Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of life related to the process of swallowing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of dementia care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude towards dementia care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preventive practice of dementia care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: antidrug knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean serum urate level reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum inflammatory factors (hs-CRP, MMP-9, IL-6, IL-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Respiratory reaction indices (RI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 5 s peak power output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding Academic Research Consortium type 2, 3, or 5 bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Power spectra shifts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of state anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decisional conflict regarding postevaluation plan
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intention to talk to physician about participating in a tobacco treatment trial
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Seeking more information about participating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improved perceptions of smoking cessation research
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fall rate ratios (falls/person/year)
Endpoint domain: Mortality/survival
Primary endpoint: 10-year prostate cancer specific mortality (PCSM)
Endpoint domain: Mortality/survival
Primary endpoint: program satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: use of intervention techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean plasma HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological distress (Kessler 6 score ≥ 5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in HF symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in Cross-Sectional Area (CSA) of cephalic vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Increase in Cross-Sectional Area (CSA) of basilic vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Inter-reader agreement (BAPL score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence score of visual reading
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: expected likelihood of concussion reporting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of hospital stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median post-operative morphine equivalents consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oxygen consumption (O2) at AT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart rate at AT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: workload at AT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pain relief from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in EuroQol 5-dimensional questionnaire index score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: participant satisfaction with treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VAS scores of incision and viscera
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration for the first rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: requirements of rescue analgesia within 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in respiratory support status within 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: maximal voluntary isometric plantar flexor torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: isokinetic plantar flexor torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: evoked peak twitch amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean total academic skills score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CIHL at PTA8-12.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 1 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Poor neurologic outcome at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: RHM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KA/KYN ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum concentrations of KA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: QA/KA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: whole-body BMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: whole-body-less-head BMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: head BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adverse Drug Events (ADEs) within 30 days of discharge
Endpoint domain: Adverse events/effects
Primary endpoint: Deprescribing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal vessel density (VD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HTP harm perceptions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: visual discomfort from floaters
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: vitreous opacity areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: photopic functional contrast sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in office DBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: T-DXd pharmacokinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DXd pharmacokinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life as measured by the Quality of Life in Alzheimer Disease
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Motor difficulty as measured by the Palliative Performance Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive scores as measured by MoCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin blood perfusion after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early SUI post-EEP prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: more than 3 NBCs in an individual case at 1 week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased risk of cardiovascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CTDIvol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: DLP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Barrier functions improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-AIT APT negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTCs detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalization for worsening heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospitalization for symptomatic ventricular arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PAED reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS‐11 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective rate of pain management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAS grade improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RFS events
Endpoint domain: Mortality/survival
Primary endpoint: Differentially expressed lncRNAs (DELs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Affordability of healthy diets for low income households
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PedQL fatigue scores for sleep
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Total fatigue scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Patient preference for ELS vs ETB
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in mean Hb level during the evaluation period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average daily number of urinary symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of decline in eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Advance directive signing rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anesthesia induction success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: liver and renal function tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Levels of presence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: First- and second-order theory of mind
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: self-perception of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caesarean section risk
Endpoint domain: Adverse events/effects
Primary endpoint: high-sensitivity C-reactive protein (hs-CRP) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 8-isoprostane F2α (PGF2α) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in BDNF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alterations in DNA methylation at neurodevelopmental genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cumulative postoperative morphine equivalent consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic root growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acknowledgement of depression as stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant deaths per 1000 live births
Endpoint domain: Mortality/survival
Primary endpoint: Humoral inflammatory response parameters (IL‐1, IL‐6, TNF‐α)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Posterior teeth intrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior open bite closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in Fugl‐Meyer Assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TAS fixation accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Score of pain degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective sleep quality score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Prevalence of unintentional injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of hard dental tissues removed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for blood product transfusions
Endpoint domain: Adverse events/effects
Primary endpoint: blood ketones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: graft uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: air conduction thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RSV A infections prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: RSV B infections rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: RSV hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Positive attitudes toward older adults
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Unscheduled cardiologist visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Unscheduled pediatrician visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mucosal visibility score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission rates at 24 h after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disappearance rates of migraine at 2 and 24 h after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child food responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child eating satiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of triglyceride, total cholesterol, low-density lipoprotein, and fasting blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WST level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum levels of hemoglobin, albumin, total protein, IgA, IgM, and IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity of diagnostic tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median prepatent period in days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune response for additional B strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: plasma glucose recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tongue muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall parenting stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing